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Abstract  
Medical device regulations across the globe have significant variations. The Chinese medical 
device market, like China’s economy, is developing rapidly. This article reviews the medical 
device regulations in China and illustrates the major changes that have been recently implemented 
according to the new medical device regulations that came into force on the 1st June, 2014. Most 
regulatory research has focused on the US and EU medical device regulations with little written 
about the Chinese medical device regulations. The purpose of this article is to bridge the research 
gap and to introduce the Chinese medical devices regulatory environment to investors or 
companies who are engaged in the medical device market or doing business in China.   
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1. Introduction 
“Medical Devices” — covers a very broad area, from simple but essential products (such as a 
wheelchair) to complex high-tech products (such as a pacemaker). Unlike ordinary products, 
medical devices utilise a large number of the latest achievements of modern science and 
technology and play a significant role in promoting human health. Due to the potential health risks, 
and the evaluation of the safety and effectiveness of medical devices, many countries have 
established medical device regulations for their supervision and management. Medical devices 
must be qualified by passing the safety and effectiveness procedures before they can be marketed 
in any particular country. 
       The US was the first country to legally define a ‘medical device’, and also was the first country 
to establish a medical devices management procedure.1 As the second largest medical devices 
manufacturers and consumers in the world, the EU also has a rich history of medical devices 
regulation. The US and EU have established relatively mature medical device regulations, which 
have a key influence in the world. For instance, most of the guidance documents of the Global 
Harmonization Task Force (GHTF)i are based on the US and the EU medical device regulations. 
China established ‘Regulations for the Supervision and Administration of Medical Devices’ in 
2000; these regulations aim to strengthen the supervision and administration of medical devices, 
ensuring their safety and protecting human health and life. The Chinese State Council released 
new Regulations for the Supervision and Administration of Medical Devices and these came into 
force on June 1st, 2014. The revisions are intended to create a more scientific and efficient 
regulatory regime for medical device supervision. There is little research into the Chinese medical 
device regulations because compared with the relatively mature US and EU regulations, Chinese 
regulations are evolving with the new regulations just released, hence there is a requirement for 
more research in this area. In this article, we describe the differences between the “Old Regulations” 
and the “New Regulations” to bridge the research gap. Generally speaking, the New Regulations 
moderate the supervision on low-risk devices and strengthens the oversight of high-risk devices. 
Thus, this article bridges the research gap and contributes to the Chinese medical device 
regulations area.  
 
2. Medical Device Regulation in China 
In the year of 1938, the US congress passed the Federal Food, Drug, and Cosmetic Act (the Act). 
The Act made provisions for medical devices. The US Food and Drug Administration (FDA) has 
the primary authority to oversee and manage medical devices, to make sure that the manufacturers 
produce safe and effective medical equipment.  
     Until the 1990s, in the area of medical devices, the EU enacted three directives to replace each 
member state’s regulations. The directives harmonised the EU medical devices market, ensuring 
medical device safety and a high level of protection for human health and effective functioning of 
the “single market”.   
      Relatively speaking, the Chinese medical device regulations were established late. In 2000, 
“Regulations for the Supervision and Administration of Medical Devices” were established, the 
regulations laid down the legal status of medical devices’ supervision and management. This was 
a milestone in China’s medical device regulation history. The “Regulations” gave the China Food 
and Drug Administration (CFDA) authority to oversee medical devices and ensure their safety and 
effectiveness, and protect human health and life.  
                                                          
i The organization GHTF (was born in 1992) has been permanently replaced by the International Medical Device 
Regulators Forum (IMDRF) in 2011. 
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     China’s definition for medical devices can be found in the Regulations for the Supervision and 
Administration of Medical Devices, 2000.2 Medical devices are defined as: 
    Any instrument, apparatus, material, or other article whether used alone or in combination, including the software 
necessary for its proper application. It does not achieve its principal action in or on the human body by means of 
pharmacology, immunology or metabolism, but which may be assisted in its function by such means; the use of which 
is to achieve the following intended objectives: 
1. Diagnosis, prevention, monitoring, treatment or alleviation of disease; 
2. Diagnosis, monitoring, treatment, alleviation of or compensation for injuries or handicap conditions; 
3. Investigation, replacement or modification for anatomy or a physiological process; 
4. Control of conception. 
     Similar to the US medical devices regulation, the CFDA classify medical devices into three 
classes.2 Class I devices are those for which safety and effectiveness can be ensured subject to 
routine administration (general controls) and do not need clinical trials; Class II devices need 
further controls (special controls) to ensure their safety and effectiveness. Class III devices are 
subject to strict controls because these kinds of devices may be implanted into the human body, or 
be for life support, they have the potential to put the patient’s life at risk. For example: artificial 
heart valves or artificial kidney. The Chinese medical device registration system is different from 
the US system and EU system. In China, Class I devices are inspected and approved by the city’s 
CFDA (city level). The province’s CFDA (province level) are responsible for Class II devices’ 
inspection and registration certificate. All the Class III devices are controlled by the State Council 
CFDA/central CFDA (national level).3 Most Class I devices can be registered for production 
directly but must follow general controls. Class II and III devices’ registration is not only subject 
to special and strict controls, but also requires clinical trial evaluation before they are put into 
production. Furthermore, when importing medical devices into the Chinese market for the first 
time, no matter what the class level is, the central CFDA will be responsible for the device’s 
supervision and administration. The importer needs to provide details of the devices’ intended use, 
quality standards, testing methods, product sample and other relevant documents for the central 
CFDA oversight.  
     The US FDA has established classifications for about 1,700 distinct types of medical devices 
and organized them into 16 medical specialty “panels” such as cardiovascular devices or ear and 
nose devices. These panels can be found in 21 CFR Part 862-892.4, 5 These actions ensure that all 
the devices on the US market have scientific and unique names. The Class I and Class II devices 
accounted for 90% of medical devices in the US market, from which 47% of medical devices fall 
under Class I and 43% fall under Class II. 10% of medical devices fall under Class III (see Table 
1). In addition, about 95% of Class I devices and a small number of Class II devices (about 8%) 
are exempt from the premarket notification process.6     
Table 1. Percentage breakdown of medical devices classification levels.  
Country/Class Class I devices Class II devices Class III devices 
US 47% 43% 10% 
China 36% 41% 23% 
 
     The Chinese medical device classification criteria are similar to the US’s. The CFDA classify 
the devices into three classes, see Table 1. There are no more than 5,000 types of medical devices 
in the Chinese market, but there are more than 60,000 devices that have the registration certificate 
issued by the CFDA regulatory agencies.7 The reason for this is that under the old standard, the 
naming of devices was inconsistent, this results in the same products having different names or the 
same names may be different products. In contrast, in the US, one device can only have one name 
4 
 
and one product code; different products have different names and codes. The US FDA device 
classification system is a database system associated with an expert group providing technical 
support; the EU devices classification system is based on the ‘Directives Rules’. The CFDA uses 
the devices ‘classification rules’ and ‘classification catalogues’ to implement the medical devices 
classification. For instance, when a device needs to be classified, the reviewers will first look for 
classification catalogues, if the product does not appear in the catalogues, the reviewers will 
classify the device according to the ‘classification rules’. In addition, only about 8%-10% of 
medical devices are classified as high-risk devices in the US whereas more than 20% of devices 
are classified as high-risk devices in China, see Table 1. For instance, the computed tomography 
(CT) scanner was classified into Class II devices in the US,8, 9 while it is classified into Class III 
in China.10 Too many products are classified as high-risk devices in China. This not only brings a 
heavy economic burden to the manufacturers, but also creates high cost and low efficiency for the 
government management. The US FDA pays more attention to review 10% high-risk Class III 
devices because they are usually the new products using new technology; In China, Class III 
devices accounted for 23% of the total devices, but, high-risk and innovative products do not 
exceed 5% of total applications for registration.11 
     The Chinese medical device registration system is a hierarchical system, see Figure 1. This 
system theoretically should have a short processing time and high efficiency but can be slow. The 
CFDA has local regulatory agencies, which includes 31 provincial, 433 municipal and 1,936 
county-level agencies. Technical organizations include 16 state, 122 provincial, 373 municipal  
and 436 county-level organizations.12 The regulatory agencies (except county-level), can issue 
medical device registration certificates.  
 
Manufacturers
City CFDA
Province CFDA
State Council CFDA
Class I 
Class II
Class III 
 
Figure 1 CFDA registration system   
      
    Medical devices in China are covered by China National Standards (GB standards) and 
professional/industry standards (YY standards).13 Medical devices must at least meet the 
requirements of the Chinese GB standards or professional standards, or meet other standards like 
ISO or equivalent if the devices want to sell in the Chinese market. Some medical devices still 
need the China Compulsory Certification (CCC) mark for product safety, such as medical 
diagnostic X-ray equipment, electrocardiograph, pacemaker, etc.14  
     China established the adverse events monitoring system and information networks, medical 
devices re-evaluation and medical device recalls but these systems are still under construction and 
need more legislative support.  
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     The mission of the CFDA is: public health protection and to ensure that all the marketed 
medical devices are safe and effective. The CFDA usually carries out random testing for medical 
devices’ manufacturers and users. The CFDA has established the adverse events systems to collect 
all the information on medical devices surveillance, this encourages medical devices related people 
to report any medical devices relevant information, like quality issues and serious injuries or deaths 
of patients.15 
 
3. The New Medical Device Regulation in China—Major Changes 
The Chinese State Council released the new Regulations for the Supervision and Administration 
of Medical Devices in 2014. Compared with the old regulations (48 articles), the new ones have 
80 articles and many changes on device registration; clinical trials; adverse events; recalls, etc. 
The new regulations are consistent with the goal of the “National 12th five-Year Plan”ii to foster 
innovation and encourage domestic companies’ research and development while enhancing the 
protection of public health.16 The government overhauls the regulations in order to catch up with 
the fast development in the medical device industry and economy.  
     According to the New Regulations, the revised definition of medical devices are:17 
Any instrument, apparatus, appliance, in-vitro diagnostic reagent and calibrator, material, or other articles alike, 
including the necessary software, directly or indirectly used on human body, which functions by means of physical 
ways, instead of by means of pharmacology, immunology or metabolism, or the participation of pharmacology, 
immunology or metabolism means only plays an assistive role; the use of medical devices is to achieve the following 
expected purposes: 
1. Diagnosis, prevention, monitoring, treatment or alleviation of disease; 
2. Diagnosis, monitoring, treatment, alleviation of or compensation for injuries or handicap conditions; 
3. Investigation, replacement, modification or support of a physiological structure or process; 
4. Supporting or maintaining of life; 
5. Control of conception; 
6. Providing information for treatment or diagnosis purpose by inspecting the samples from human body. 
 
3.1.Classification of Medical Device 
The New Regulations classify and administer medical devices based on their risk levels. Class I 
medical devices are those with a low-risk level, which through routine administration their safety 
and effectiveness can be ensured; Class II medical devices are those with a middle-risk level, for 
which strict control and administration is required to ensure their safety and effectiveness; Class 
III medical devices are those with a higher-risk level, for which special measures and strict control 
shall be taken to ensure their safety and effectiveness. Compared with the old regulations, the new 
regime introduces risk management into the regulations. Risk management not only in the device 
classification sections, but also in other parts. For example, “medical device registration should 
submit a risk analysis report of the product; medical device recalls and adverse events”.  
 
3.2.Medical Device Registration 
According to the New Regulations, Class I devices will no longer require registration, but will 
change to record-filing. The applicant shall submit the required documents to a city level 
regulatory authority (same as the Old Regulations) for device record-filing procedure. The 
applicant shall submit the following material to the regulatory authority for Class I devices record-
                                                          
ii Five-Year Plan (FYP) is a series of social and economic development initiatives, which renews every five years. The Five-Year 
Plan was shaped by the Communist Party of China, who plays a leading role in mapping strategies for China’s economic 
development, setting growth targets and launching reforms. First FYP: 1953-1957, the rest can be done in the same manner. So 11th 
FYP is from 2006-2010 and 12th FYP is from 2011-2015. 
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filing and Class II and Class III devices registration: (1) Risk analysis report of the product; (2) 
Technical requirements of the product; (3) Testing report of the product; (4) Clinical trial material; 
(5) Product instructions for use and sample label; (6) Quality management system documentations 
related to research and development (R&D) and manufacturing of the product; (7) Other 
documents which prove the safety and effectiveness of the product. Moreover, the applicant for 
the medical devices record-filing or registration shall be responsible for the authenticity of the 
submitted documents.18 Like the Old Regulations registration procedure, Class II devices are 
administered by a provincial regulatory authority and Class III devices are administered by the 
central CFDA. Class I devices do not require clinical trials for the record-filing procedure, Class 
II and Class III devices require clinical trials for registration. However, clinical trials can be 
exempted in any of the following circumstances: the device is at least as safe and effective as a 
previously cleared (predicate) device (legally Chinese marketed device), which has similar 
intended use and no severe adverse events record; a medical device which proves to be safe and 
effective through non-clinical evaluation assessments; a medical device which proves to be safe 
and effective through the analysis and evaluation of the data obtained from clinical trials or clinical 
application of the substantially equivalent medical devices. In addition, the duration of the medical 
device registration certificate is five years (the Old Regulations suggest the registration certificate 
must be renewed every four years). 
 
3.3.Medical Device Production 
The New Regulations pay more attention to Good Manufacturing Practices (GMPs) for medical 
device production management. GMP is that part of quality assurance, which ensures that medical 
products are consistently produced to the required product specification and controlled to the 
quality standards appropriate to their intended use. GMP is concerned with both production and 
quality control.19  
     CFDA requires that all the medical devices in the Chinese market should be accompanied with 
product specifications and labels. In addition, the New Regulations require Class II and Class III 
devices should also indicate the registration certificate number and register’s affiliations with 
product specifications and labels. Moreover, if the medical device can be used by the consumer 
independently, the product specifications and labels should include special instructions for its safe 
use.  
     According to the New Regulations, if a medical device is within a manufacturing consignment, 
the consigner shall be responsible for the quality of medical devices. The consignee shall be a 
medical device manufacturer which meets the CFDA’s requirements. In addition, the imbedded 
medical devices with a high-risk level shall not be manufactured in consignments.20 
 
3.4.Distribution/Operation and Use of Medical Devices   
The Old Regulations required companies who distribute/operate Class I medical devices to file 
records with the provincial CFDA. Companies distributing/operating Class II and Class III medical 
devices need to obtain the Medical Device Distributing Enterprise License, which is issued by the 
provincial CFDA. The New Regulations removes record-filing for Class I device distributors and 
requires Class II device distributors to file records with the provincial CFDA.  
     The New Regulations also place more obligations on medical device distributors and users. 
Such obligations cover all aspects of using medical devices including device supplier’s certificates, 
quality certificates, records of purchase/sales, transportation and storage, operator technical 
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training. Moreover, the medical device user shall inspect, verify and maintain the devices 
periodically to ensure the devices are in good condition, safe and effective.  
     Imported medical devices shall be accompanied with product specifications or user manuals 
and labels in Chinese, and specify the devices’ place of origin and agent’s affiliations. The medical 
device exporters shall ensure the exported devices comply with the requirements of the importing 
countries. 
 
3.5.Medical Device Adverse Events and Recalls  
The Old Regulations were silent about medical device adverse events and recalls. However, the 
central CFDA and the Chinese Ministry of Health (MOH) issued provisional Decree 425 for 
tracking adverse events21 and provisional Decree 82 for managing medical device recalls22 in 2011, 
respectively.  
     The New Regulations issued requirements on monitoring medical device adverse events and 
managing recalls. These requirements set clear responsibilities from device manufacturer 
personnel to distributors and patients/consumers. The central CFDA established the medical 
device adverse events monitoring system and information networks to: collect information, 
analyse, evaluate and control adverse events in a timely manner. Any medical device manufacturer, 
distributor and user has rights to report adverse events to this monitoring system and information 
networks, and the CFDA will also collect adverse events information proactively.  
     The New Regulations require the device manufacturer to stop production if the device does not 
meet the compulsory standards or contains other defects, furthermore, they must notify relevant 
distributors or users to stop distributing or using this kind of device and recall the devices which 
are already on the market. According to MOH Decree 82, there are three levels of recalls based on 
the severity of medical device defects.22 Level I recalls means that if use of the medical device has 
caused, or may cause, serious health hazards that are of a permanent nature; Level II recalls means 
use of the medical device may cause health hazards that are of a temporary or permanent nature; 
Level III recalls mean use of the medical device may not be likely to cause harm but it is still 
defective.14  
 
3.6.Supervision and Inspection 
The New Regulations require that the CFDA enhance supervision and inspection of medical 
devices’ registration, record-filing, production, distribution and use, sometimes using random 
checks. The provincial CFDA or central CFDA will issue medical device quality circulars based 
on the results of timely random checks.  
     The central CFDA has established a shared medical device supervision and inspection 
information network. The CFDA should legally and in a timely manner publish the medical 
devices’ license, record-filing, random check results and illegal behaviour through the information 
network. In addition, the CFDA also established the credit files for medical device registrants, 
record-filing applicants, manufacturers, distributors and users, and increased the frequency of 
inspection upon those who have a poor credibility record. Moreover, the CFDA publish their 
contact information for inquires, complaints and reports. Information disclosure is a major 
breakthrough for the Chinese medical device market participants’ supervision and inspection. 
 
3.7.Legal Liabilities 
The New Regulations have increased sanctions and penalties for various violations. For example, 
administrative penalties up to 20 times (5 times in the Old Regulations) the value of the 
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manufactured products may be imposed on medical devices produced without the proper permits. 
In some severe circumstances, relevant personnel and companies will be suspended from 
application for any medical device permits or licences for 5 years, and may be subject to criminal 
sanctions if such violation constitutes a criminal offense. Penalties or criminal offenses may be 
incurred for the following actions: permits (medical device registration certificate, production 
permit, distribution permit, advertisement approval certificate) are obtained by providing false 
information or by using other methods of cheating;  relevant medical device permits or certificates 
are forged, altered, transferred, leased and lent; manufacture, distribute or use of devices which 
are not compliant with the compulsory standards or technical requirements; any clinical trials 
conducted in violation of the Regulations or medical device clinical trial institutes issuing false 
reports, etc.  
 
4. Discussion 
The New Regulations are intended to establish a more efficient and scientific regulatory regime 
for supervision and administration of medical devices. Risk management has been introduced to 
the New Regulations such as device classification. In addition, the CFDA pays more attention to 
the Class III devices supervision and moderates the Class I devices oversight. The Old Regulations 
required that all the Class II and Class III devices need clinical trials, inspection and approval by 
the provincial CFDA and central CFDA, respectively.3 The exemption from clinical trials for some 
special circumstances has been introduced in the New Regulations. Moreover, the registration 
certificate is replaced by record-filing for Class I devices application, which make the registration 
process more efficient.  
    As previously described, due to there not being a national unified product naming and coding 
system; too many devices are classified as high-risk devices when they should not be categorised 
at the high-risk level, resulting in an unnecessary waste of effort and low efficiency of medical 
device supervision in China. Nevertheless, the New Regulations have tried to establish a unique 
unified national medical device naming and coding system, to reduce the number of: “the same 
products having different names or the same names referring to different products” , and the central 
CFDA will analyse and evaluate medical device’s risk, to adjust the “classification catalogue”.23   
     In the US and EU, the legislation clearly prescribes that the device manufacturer or applicant 
will take the main responsibilities for device safety and all the consequences resulting from the 
device performance. However, the old legislation did not clearly define this situation, the CFDA 
bears some responsibility for the medical devices’ use, failures, and even adverse events. The New 
Regulations clearly delineate every medical device related participant’s responsibilities. For 
example, medical device manufacturers, distributors and users shall monitor adverse events. If any 
adverse events are identified, they shall report it to the medical device adverse event monitoring 
technique institutes.24  
     The post-market surveillance is an important guarantee to ensure that the devices continue to 
be safe and effective. The US and EU’s medical devices regulatory legislation have strict 
requirements for the marketed devices. For example, the EU has the vigilance system for post-
market surveillance, such as the European Databank on Medical Devices (EUDAMED)iii. The 
adverse events and recall of medical devices does not appear in the Old Regulations. The New 
                                                          
iii EUDAMED contains data on manufacturers, authorized representatives and devices; certificates issued, modified, supplemented, 
suspended, withdrawn or refused; clinical investigations, which use is obligatory since May 2011. The purpose of EUDAMED is 
to enhance market surveillance and transparency in the medical devices area by providing Competent Authorities with quick access 
to information as well as to contribute to a uniform application of the Directive. 
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Regulations combined the central CFDA Decree 425 and MOH Decree 82 requirements, they 
clearly describe the device participants’ responsibilities and have established the medical device 
adverse events monitoring system and information networks to control adverse events and recalls; 
they have established a re-evaluation system for registered medical devices to regulate supervisory 
activities.  
 
5. Conclusions 
The changes made in the New Regulations demonstrate the Chinese government’s efforts to 
upgrade and maintain an effective regulatory framework for the medical device market. The 
Chinese government has promulgated the New Regulations, which covers various perspectives of 
the regulatory regime of medical devices, such as device classification and registration, 
supervision of production and distribution, etc. Driven by the more powerful regulatory 
requirements under the New Regulations, the Chinese medical device market will become 
increasingly dynamic in the future.  
     Further in-depth research on this topic will be carried out in the future. Some regulations and 
policies still need modification and the recommendation is for more studies to understand the 
changing market environments, this should result in continuous improvement of policies. 
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